West Virginia Bill Could Empower Juries With More Relevant Evidence
Bill on seat belt admissibility heads to Governor
GlaxoSmithKline v. State of Louisiana
(U.S., filed August 8, 2018): Arguing that a State cannot invoke sovereign immunity to avoid being bound by a class settlement and, instead, bring a new lawsuit making identical claims when the State was expressly included in the class, received notice of the action and settlement, and did not opt out.
On December 18, 2018, the petition for cert was dismissed.
Latest News
View all news
Brief Calls Out Joining Dissimilar Claims in Missouri Talc Suit
SCOTUS Determining Whether to Hear Appeal by Defendant
Florida Enacts Covid Liability Protections
Florida Governor Ron DeSantis signs covid liability protections into law in the state which has seen a disproportionate amount of legal services ads related to the COVID-19 pandemic.
Garland Should Oppose Biden Effort to Reinstate Controversial ‘Slush Funds’ Practice
Writing for The Hill, ATRA President Tiger Joyce discusses the Biden administration’s plans to allow a settlement slush fund and issues the practice has caused at the state level.
With This Missouri Case, the Supreme Court Could Curb Activist State Judiciaries
ATRA President Tiger Joyce writes about issues with a landmark talc case in Missouri and how the U.S. Supreme Court can step in.
West Virginia Legislature Looks to Address COVID-19 Liability
Trial lawyers’ spending on covid ads last year surpassed $260,000